FDA and NCI Collaborate on Secure Data Repository for Investigational Drugs Research

Summary

The Food and Drug Administration (FDA) has signed a Memorandum of Understanding (MOU) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to create a secure data repository for research on investigational drugs. This collaboration aims to facilitate the electronic exchange and analysis of data from research studies.